During a recent Ohio site inspection by the FDA it was discovered that warning statements needed to be included with the product shipment.
Source facts
Action
A letter dated April 14, 2016 was sent to customers. The letter stated the reason for the recall. It also informed customers that there is no impact on the performance of the assay. Customers were asked to either visit the IVD web portal (www.affymetrix.com/ivd) and review the warning statements; or, request a hard copy free of charge.
Initiated
2016-04-14
Root cause
Labeling design
Terminated
2016-08-17
Distribution
Distributed in the US to the states of AR, CA, DC, MI, MA, MN, NC, NM, NY, PA, SC, TN, TX, WA and WV.
Recall number
Z-1909-2016
Recall status
Terminated
CDRH record ID
145817
FDA record created
2016-06-03
Recall event number
73979
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.